Cancer treatment data available in European cancer registries: Where are we and where are we going?
Open Access
- 8 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1109978
- https://doi.org/10.3389/fonc.2023.1109978
Abstract
Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their activities to studies on cancer aetiology, prevention, and quality of care. This expansion relies also on the collection of additional clinical data, such as stage at diagnosis and cancer treatment. While the collection of data on stage, according to international reference classification, is consolidated almost everywhere, data collection on treatment is still very heterogeneous in Europe. This article combines data from a literature review and conference proceedings together with data from 125 European cancer registries contributing to the 2015 ENCR-JRC data call to provide an overview of the status of using and reporting treatment data in population-based cancer registries. The literature review shows that there is an increase in published data on cancer treatment by population-based cancer registries over the years. In addition, the review indicates that treatment data are most often collected for breast cancer, the most frequent cancer in women in Europe, followed by colorectal, prostate and lung cancers, which are also more common. Treatment data are increasingly being reported by cancer registries, though further improvements are required to ensure their complete and harmonised collection. Sufficient financial and human resources are needed to collect and analyse treatment data. Clear registration guidelines are to be made available to increase the availability of real-world treatment data in a harmonised way across Europe.This publication has 29 references indexed in Scilit:
- Cancer survival in Europe, 1999–2007: Doing better, feeling worse?European Journal of Cancer, 2015
- Uses of cancer registries for public health and clinical research in Europe: Results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010–2012European Journal of Cancer, 2015
- EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluationEuropean Journal of Cancer, 2015
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP-3 surveyInternational Journal of Cancer, 2012
- Breast cancer survival in the US and Europe: A CONCORD high‐resolution studyInternational Journal of Cancer, 2012
- Tumor Markers in Clinical Practice: A Review Focusing on Common Solid CancersMedical Principles and Practice, 2012
- Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timelinessEuropean Journal of Cancer, 2009
- Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results☆European Journal of Cardio-Thoracic Surgery, 2009
- Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987European Journal of Cancer, 1996